Research Areas
Drug Pricing and Cost
Drug pricing is a key issue in the United States, and CP3 faculty regularly use their expertise to contribute to public discourse on many aspects of drug pricing and health care costs.
Risk Prediction
Our group conducts pivotal work that addresses the opioid epidemic by developing overdose risk prediction tools using machine learning and building the foundation for implementing these tools in practice.
Pharmacoepi
Our faculty are national experts in pharmacoepidemiology and conduct research to enable prescribers to make safe, informed decisions for their patients.
Access & Shortages
CP3 focuses on identifying and addressing obstacles to obtaining medications and treatments. These projects aim to inform policies and interventions that improve medication access, affordability, and health outcomes across different populations.
Our Team Improves Medication Use Through Evidence, Policy, and Collaboration
The team at the Center for Pharmaceutical Policy and Prescribing (CP3) is composed of nationally recognized experts in health policy, clinical medicine, pharmacy, epidemiology, economics, and data science. Our interdisciplinary group includes faculty and researchers from the Schools of Medicine, Pharmacy, and Public Health, all united by a shared commitment to improving medication use and pharmaceutical policy. With deep expertise in pharmacoepidemiology, real-world evidence, health services research, and policy analysis, CP3 team members work collaboratively to generate impactful research, inform policy decisions, and mentor the next generation of scholars and clinicians.
